» Articles » PMID: 27172994

Protein S is Protective in Pulmonary Fibrosis

Overview
Publisher Elsevier
Specialty Hematology
Date 2016 May 14
PMID 27172994
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Essentials Epithelial cell apoptosis is critical in the pathogenesis of idiopathic pulmonary fibrosis. Protein S, a circulating anticoagulant, inhibited apoptosis of lung epithelial cells. Overexpression of protein S in lung cells reduced bleomycin-induced pulmonary fibrosis. Intranasal therapy with exogenous protein S ameliorated bleomycin-induced pulmonary fibrosis.

Summary: Background Pulmonary fibrosis is the terminal stage of interstitial lung diseases, some of them being incurable and of unknown etiology. Apoptosis plays a critical role in lung fibrogenesis. Protein S is a plasma anticoagulant with potent antiapoptotic activity. The role of protein S in pulmonary fibrosis is unknown. Objectives To evaluate the clinical relevance of protein S and its protective role in pulmonary fibrosis. Methods and Results The circulating level of protein S was measured in patients with pulmonary fibrosis and controls by the use of enzyme immunoassays. Pulmonary fibrosis was induced with bleomycin in transgenic mice overexpressing human protein S and wild-type mice, and exogenous protein S or vehicle was administered to wild-type mice; fibrosis was then compared in both models. Patients with pulmonary fibrosis had reduced circulating levels of protein S as compared with controls. Inflammatory changes, the levels of profibrotic cytokines, fibrosis score, hydroxyproline content in the lungs and oxygen desaturation were significantly reduced in protein S-transgenic mice as compared with wild-type mice. Wild-type mice treated with exogenous protein S showed significant decreases in the levels of inflammatory and profibrotic markers and fibrosis in the lungs as compared with untreated control mice. After bleomycin infusion, mice overexpressing human protein S showed significantly low caspase-3 activity, enhanced expression of antiapoptotic molecules and enhanced Akt and Axl kinase phosphorylation as compared with wild-type counterparts. Protein S also inhibited apoptosis of alveolar epithelial cells in vitro. Conclusions These observations suggest clinical relevance and a protective role of protein S in pulmonary fibrosis.

Citing Articles

Administration of Gas6 attenuates lung fibrosis via inhibition of the epithelial-mesenchymal transition and fibroblast activation.

Lee Y, Kim M, Kim H, Kang J Cell Biol Toxicol. 2024; 40(1):20.

PMID: 38578518 PMC: 10997547. DOI: 10.1007/s10565-024-09858-5.


Deciphering the contributions of cuproptosis in the development of hypertrophic scar using single-cell analysis and machine learning techniques.

Song B, Liu W, Zhu Y, Peng Y, Cui Z, Gao B Front Immunol. 2023; 14:1207522.

PMID: 37409114 PMC: 10318401. DOI: 10.3389/fimmu.2023.1207522.


Single-Cell RNA Sequencing Provides New Insights into Therapeutic Roles of Thyroid Hormone in Idiopathic Pulmonary Fibrosis.

Wang L, Li Z, Wan R, Pan X, Li B, Zhao H Am J Respir Cell Mol Biol. 2023; 69(4):456-469.

PMID: 37402274 PMC: 10557923. DOI: 10.1165/rcmb.2023-0080OC.


Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis.

DAlessandro-Gabazza C, Yasuma T, Kobayashi T, Toda M, Abdel-Hamid A, Fujimoto H Nat Commun. 2022; 13(1):1558.

PMID: 35322016 PMC: 8943153. DOI: 10.1038/s41467-022-29064-3.


Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy.

Pisoschi A, Pop A, Iordache F, Stanca L, Geicu O, Bilteanu L Eur J Med Chem. 2022; 232:114175.

PMID: 35151223 PMC: 8813210. DOI: 10.1016/j.ejmech.2022.114175.